Dual attack supercharges cells to eliminate metastatic breast cancer – New Atlas
Metastatic breast cancer is stubbornly resistant to current immunotherapies. But scientists have identified a dual-therapy attack to really fire …
» Read moreMetastatic breast cancer is stubbornly resistant to current immunotherapies. But scientists have identified a dual-therapy attack to really fire …
» Read moreLauren M. Hurwitz, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues examined whether the association between frequent …
» Read moreWhile some delayed exams in the height of the COVID-19 pandemic, an Epic Research study finds no increase in cancer cases.
» Read moreAstraZeneca said on Monday a mid-stage trial of its cancer drug Enhertu showed positive results across multiple HER2-expressing advanced solid …
» Read moreSINGAPORE – Subsidised cancer patients will receive higher insurance coverage for cancer treatment services from April 1 following a review.
» Read moreFRIDAY, March 3, 2023 (HealthDay News) — Breast cancer risk estimates for individual women vary substantially depending on which risk assessment …
» Read moreJapanese company Denka, along with US chemicals giant DuPont, have operated the plant that produces cancer-causing chloroprene.
» Read moreFan of Intermittent Fasting? It Could Increase the Risk of Cancer | Vantage with Palki Sharma. New research links intermittent fasting to an …
» Read moreColon cancer is generally thought to be a problem that affects older people. But doctors are observing a steady increase in the number of cases …
» Read moreImmunotherapy stimulates the body’s immune system to recognise and combat cancer cells while not directly affecting the tumour cell.
» Read moreSydney Kids Cancer Centre specialist David Zielger says clusters of rare diseases are not uncommon. (Supplied: UNSW Sydney).
» Read moreDr. Shirpa Gandhi, Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, joins the Oncology Brothers (Drs. Rohit & Rahul.
» Read more